Vertex Pharmaceuticals, Inc.

VRTX

$216.11

-17.14% (1 year change)

Avg closing price

Price range

Market Cap

$56.8 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$1.54 Billion

Total revenue in the last quarter.

Net Income

$667 Million

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$10.29

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

20.94x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$674 Million

Earnings before interest expenses and taxes in the last quarter.

Employees

0

The number of full time employees.

Revenue & Earnings

Balance Sheet

News

Vertex Pharmaceuticals: Dominant moat, strong pipeline

Vertex Pharmaceuticals: Dominant moat, strong pipeline

Vertex Pharmaceuticals, Value Stocks

The Edge Singapore The Edge Singapore, 2 months ago
Michael Parini Sells 1,930 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock

Michael Parini Sells 1,930 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) EVP Michael Parini sold 1,930 shares of the firm’s stock in a transaction dated Friday, February 5th. The stock was sold at an average price of $21...

Watchlist News Watchlist News, 2 months ago
Michael Parini Sells 400 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock

Michael Parini Sells 400 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) EVP Michael Parini sold 400 shares of the firm’s stock in a transaction on Wednesday, February 3rd. The shares were sold at an average price of $21...

Watchlist News Watchlist News, 2 months ago